TAVR Heart Valves

Awarded Limited / Sole Source Justification Posted

Solicitation number
36C25525AP1649
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
36C25525D0045 Federal IDV award
Place of performance
California 92614, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 issued a sole source justification notice for transcatheter aortic valve replacement (TAVR) heart valves at the Harry S. Truman Memorial Veterans' Hospital. The contract (36C25525D0045) was awarded to Edwards Lifesciences LLC for an Indefinite Delivery/Indefinite Quantity agreement covering various transcatheter heart valve products, including SAPIEN 3 and RESILIA models in multiple sizes with Commander or Certitude delivery systems. The sole source procurement is justified due to Edwards Lifesciences' proprietary heart valve technology offering unique features such as precise sizing, safety mechanisms for stent folding, novel tissue preservation techniques, and expandable rings that facilitate future valve replacement procedures. The total estimated contract value is $4,261,359.80, spanning a base period and four option years from April 1, 2025, through March 31, 2030. Market research confirmed that Edwards Lifesciences has no authorized distributors and no other vendors were identified as capable of providing equivalent heart valve technology, with the VA committing to conduct annual market research to verify continued lack of alternative sources. Normal delivery is available within 48 hours, with urgent delivery options available upon advance notice.

Notice text

TAVR Heart Valves

Awarded contract 36C25525D0045 to unknown vendor for unknown amount on 2025-06-24.

Files

File Type Posted
36C25525D0045_2.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity